AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 45 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,728,402 | -31.8% | 944,505 | +9.2% | 0.00% | -33.3% |
| Q2 2023 | $14,256,765 | +121.6% | 865,095 | +23.2% | 0.00% | +50.0% |
| Q1 2023 | $6,432,894 | -19.6% | 702,281 | -37.1% | 0.00% | +100.0% |
| Q4 2022 | $7,997,699 | +51.5% | 1,116,997 | +6.0% | 0.00% | 0.0% |
| Q3 2022 | $5,278,000 | +100.5% | 1,053,520 | -2.4% | 0.00% | – |
| Q2 2022 | $2,633,000 | -19.2% | 1,078,962 | +126.3% | 0.00% | – |
| Q1 2022 | $3,257,000 | -2.8% | 476,797 | +15.0% | 0.00% | – |
| Q4 2021 | $3,350,000 | +37.5% | 414,576 | +66.8% | 0.00% | – |
| Q3 2021 | $2,436,000 | +48.0% | 248,587 | +1.7% | 0.00% | – |
| Q2 2021 | $1,646,000 | -28.5% | 244,509 | -4.0% | 0.00% | – |
| Q1 2021 | $2,302,000 | +89.5% | 254,667 | +40.1% | 0.00% | – |
| Q4 2020 | $1,215,000 | -3.0% | 181,811 | -26.8% | 0.00% | – |
| Q3 2020 | $1,252,000 | +1.5% | 248,420 | +62.7% | 0.00% | – |
| Q2 2020 | $1,234,000 | -22.5% | 152,673 | -23.8% | 0.00% | -100.0% |
| Q1 2020 | $1,592,000 | -3.4% | 200,414 | -8.2% | 0.00% | – |
| Q4 2019 | $1,648,000 | +663.0% | 218,258 | +318.6% | 0.00% | – |
| Q3 2019 | $216,000 | +39.4% | 52,136 | -3.3% | 0.00% | – |
| Q2 2019 | $155,000 | -38.0% | 53,903 | -44.4% | 0.00% | – |
| Q4 2018 | $250,000 | -64.3% | 96,885 | -39.3% | 0.00% | – |
| Q3 2018 | $701,000 | -60.6% | 159,540 | -45.0% | 0.00% | -100.0% |
| Q2 2018 | $1,777,000 | +43.5% | 289,891 | +70.7% | 0.00% | – |
| Q1 2018 | $1,238,000 | -8.5% | 169,851 | +2.9% | 0.00% | -100.0% |
| Q4 2017 | $1,353,000 | +20.9% | 165,075 | +54.9% | 0.00% | 0.0% |
| Q3 2017 | $1,119,000 | +216.1% | 106,569 | +232.2% | 0.00% | – |
| Q2 2017 | $354,000 | – | 32,080 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,305,017 | $18,625,000 | 7.73% |
| COWEN AND COMPANY, LLC | 3,732,778 | $30,161,000 | 2.74% |
| GENDELL JEFFREY L | 2,446,299 | $19,766,000 | 1.60% |
| Asymmetry Capital Management, L.P. | 369,134 | $2,983,000 | 1.58% |
| Vivo Capital, LLC | 2,937,093 | $23,732,000 | 1.43% |
| Samsara BioCapital, LLC | 659,409 | $5,328,000 | 1.03% |
| Altium Capital Management LP | 440,589 | $3,560,000 | 0.98% |
| Knott David M Jr | 258,198 | $2,086,000 | 0.71% |
| RTW INVESTMENTS, LP | 5,741,939 | $46,395,000 | 0.68% |
| FRAZIER MANAGEMENT LLC | 951,814 | $7,691,000 | 0.59% |